ALTx Therapeutics launches to develop precision therapies targeting cancers that use the Alternative Lengthening of Telomeres ...
The Global Healthcare Companion Robots Market is poised to expand at an impressive CAGR of nearly 20% between 2024 and 2029.
Total resolution of HS inflammatory lesions, including draining tunnels, for 40.1% of people at three years (IHS4-100): Additionally, 59.1% and 77.4% achieved IHS4‑90 and IHS4-75, ...
Based on the pioneering work of British scientist Simon Boulton, ALTx leverages fundamental insights in cancer cell immortalisation to develop novel treatments for cancer Spinning out of The Francis ...
IMed confirms expansion of business and implements new recruitment services for clientsOxford, 4th February 2026 – IMed Group, a leading provider of regulatory consultancy services to the global ...
Clinical Decision Support System Market OverviewThe global clinical decision support system market is projected to expand at an approximate CAGR of around 10% throughout the forecast timeline, ...
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent loss disorders, today announces ...
STIMULAN? certified to be mixed with a combination of Gram-positive and Gram-negative antibiotics STIMULAN? certified to resolve infection and reduce the need for secondary surgerySTIMULAN? is the ...
Novakand Pharma AB (publ) (“Novakand” or “the Company”) today reports that the Company has entered into a share purchase agreement with the shareholders of SVF Vaccines AB (“SVF”), whereby Novakand ...
Founded in New Zealand/Australia over 100 years ago, Nufarm is widely recognised as a global leader in crop protection and seed technology. Its products play a vital role in ensuring the safe and ...
Friday, February 6, 2026: HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; SEHK:13) will be announcing its final results for the year ended December 31, 2025 on Thursday, March 5, 2026 at ...
Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced an expansion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results